T-Bet Deficiency Attenuates Bile Duct Injury in Experimental Biliary Atresia
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Dec 2021 · 1 min read
In brief
In brief
This study demonstrates that T-bet deficiency reduces Th1-mediated immune injury in a rotavirus model of biliary atresia, preserving bile duct patency despite similar clinical symptoms. The findings suggest T-bet-driven adaptive immunity plays a critical role in bile duct destruction, offering potential therapeutic targets for this devastating neonatal liver disease.
Written by the GCMD Library team from the article.
Statements in this article
Biliary atresia is an obstructive neonatal cholangiopathy leading to liver cirrhosis and end stage liver disease.
Most biliary atresia patients ultimately require liver transplantation for survival even after Kasai portoenterostomy.
Immune cells within the liver of patients with biliary atresia at diagnosis demonstrate a T-helper 1 inflammatory profile similar to rhesus rotavirus-infected mice livers developing biliary atresia.
The transcription factor Tbx21 (T-bet) is essential for induction of a Th1 immune response in both the adaptive and innate immune system.
Infection of newborn T-bet knockout pups with rhesus rotavirus resulted in a decreased Th1 inflammatory chemokine/cytokine profile when compared to infected wild-type mice.
T-bet knockout mice infected with rhesus rotavirus showed a significant decrease in the total number of CD3, CD4, and CD8 T cells compared to wild-type mice.
T-bet knockout mice infected with rhesus rotavirus showed decreased effector molecules granzyme A, perforin, and FasL.
The percentage of T-bet knockout mice displaying symptoms of obstructive cholangiopathy was not different compared to wild-type mice.
The overall mortality rate in T-bet knockout mice was not different compared to wild-type mice.
The extrahepatic bile ducts of T-bet knockout mice remained patent despite rhesus rotavirus infection.